May 07, 2009
kosmo - See all 768 of my articles
It was a great sports day for me. Two of my least favorite sports figures made the news.
The twice retired quarterback Brett Favre told my Minnesota Vikings that he does intend to stay retired this time. I truly hope that this is his final answer. I have a great deal of dislike for Brett from his days playing for the Packers, and I would be unable to cheer for my Vikings if he was the starting quarterback. Most likely, I would have to take a short sabbatical until Favre hung up his cleats for the third time. Luckily, it appears that I will not need to go down this route.
Overshadowing Favre’s decision was the news that LA Dodgers superstar Manny Ramirez was being suspended 50 games (and losing more than $7 million in salary as a result) after testing positive for HCG, a female fertility drug. This drug is often used by steroid users to bring their testosterone level back to a normal level after steroid use had dropped it to a very low level.
Manny claims that he was given a prescription by a doctor who was not aware that the drug was on baseball’s banned substances list. I’m not buying that excuse, for a couple of reasons. First, it’s not the doctor’s responsibility to verify that a drug is OK to take, it is Manny’s responsibility. Check with the team’s medical staff and your union rep if you’re not sure. Second, Manny has decided not to appeal the suspension. If he was telling the truth, why not fight the allegation? Millions of dollars and the Hall of Fame may be at stake.
The Dodgers were already pulling away in the NL West and might have already printed playoff tickets. It will be interesting to see what they can do without Manny. They do have a decent player to plug into the spot in Juan Pierre, but Pierre’s bat does not even begin to compare to Manny’s.Share this article via email Kosmo is the founder of The Soap Boxers and writes on a variety of topics. Many of his short stories have been collected into Kindle books. Like this site? Subscribe via RSS, Subscribe via Email, or Follow us on Twitter or Facebook. The permanent URL for this article is: